According to the indicators oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), and Ki67, breast cancer is subdivided into luminal A, luminal B, HER2-positive, and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to breast carcinoma.